Bexagliflozin, sold under the brand name Brenzavvy, is an antidiabetic medication used to improve glycemic control in adults with type 2 diabetes. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that is taken by mouth.
{{Infobox drug | image = Bexagliflozin structure.svg | image_class = skin-invert-image | width = 325 | alt = | caption =
| pronounce = | tradename = Brenzavvy, Bexacat | Drugs.com = | MedlinePlus = a623027 | DailyMedID = Bexagliflozin | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = A10 | ATC_suffix = BK08 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).